171 related articles for article (PubMed ID: 3112705)
1. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Berardi-Grassias LD; Roy O
Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
[TBL] [Abstract][Full Text] [Related]
2. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antimicrobial activity of pipemidic acid on strains isolated from urine cultures of hospitalized and nonhospitalized subjects].
Ceddia T; Marinucci MC
Boll Soc Ital Biol Sper; 1980 Aug; 56(16):1629-32. PubMed ID: 6779836
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
[TBL] [Abstract][Full Text] [Related]
5. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
7. Pefloxacin: evolution of in vitro activity during 18 months of use in an intensive care unit.
Tigaud S; Marcatello A; Gille Y; Robert D; Vincent P
Drugs Exp Clin Res; 1985; 11(3):169-76. PubMed ID: 3869804
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of pefloxacin compared to other antibiotics.
Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
[TBL] [Abstract][Full Text] [Related]
9. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Soussy CJ; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1990 May; 38(5):376-84. PubMed ID: 2367152
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Neu HC; Chin NX; Labthavikul P; Saha G
Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
[TBL] [Abstract][Full Text] [Related]
13. [Activity of the amoxicillin-clavulanic acid (augmentin) combination on strains of hospital isolates].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1985 May; 33(5):301-8. PubMed ID: 3929215
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
Debbia E; Schito GC; Nicoletti G; Speciale A
Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Periti P; Mazzei T; Nicoletti P
Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
[TBL] [Abstract][Full Text] [Related]
16. [In vitro study of the combination of pefloxacin with other antibiotics against Pseudomonas aeruginosa and Streptococcus group D].
Zuccarelli M; Attisso MA; Simeon de Buochberg M; Dusart G
Pathol Biol (Paris); 1987 May; 35(5):581-5. PubMed ID: 3112710
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
Peters G; Freiesleben H; Marre R; Metz H; Tannenberg H; Pulverer G
Dtsch Med Wochenschr; 1979 Jun; 104(26):946-8. PubMed ID: 110574
[TBL] [Abstract][Full Text] [Related]
18. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
20. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
